The posters are available on the Posters and Publications page of the Company’s website.

Nvelop Therapeutics, a biotechnology company engineering programmable, non-viral vehicles for the in vivo delivery of ...

Data further validates the AnelloVector™ platform as the first gene delivery vector system based on the human commensal anellovirusCAMBRIDGE, ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Research Triangle Park, N.C., Oct. 17, 2024 () – Two oral presentations and nine poster presentations will highlight ...

The company presented data showing that a single IV dose of its ctLNP delivered mRNA encoding a reporter protein to a ...

Established in 1992, the European Society of Gene and Cell Therapy (ESGCT) seeks to support scientists and clinicians working in the fields of gene and cell therapy and to promote awareness and ...

at the European Society of Gene and Cell Therapy (ESGCT) 31st Annual Meeting taking place October 22–25, 2024, in Rome, Italy. “Our presence at ESCGT this year demonstrates our commitment to ...

gene therapy preclinical research programs in a poster session at the European Society of Gene and Cell Therapy (ESGCT) 31 st Annual Congress, being held October 22-25, 2024, in Rome, Italy.

Precision BioSciences, Inc. (Nasdaq: DTIL) is an advanced gene editing company utilizing its novel proprietary ARCUS® ...

today announced a poster presentation at the upcoming European Society of Gene & Cell Therapy (ESGCT) Congress being held October 22-25, 2024, in Rome, Italy. Presentation Details: Title ...